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Purpose of review: Vasopressin and terlipressin, a long-acting V1a analogue, are
increasingly used in intensive care. The main clinical indications are the treatment
of patients with septic shock and of patients with cirrhosis, who develop variceal
bleeding, the hepatorenal syndrome or both. In this review, we summarize the
effects of these drugs on splanchnic hemodynamics and organ function.Recent
findings: A recent systematic meta-analysis of randomized trials suggests that
terlipressin may improve renal function in hepatorenal syndrome and thereby
reduce mortality by 34%. Moreover, a recent study reported that association of
terlipressin and albumin was more effective than terlipressin alone. In patients with
variceal bleeding, the bleeding control is significantly improved by early
administration of terlipressin. The place of vasopressin in the treatment of patients
with septic shock is still discussed, but compared with norepinephrine, vasopressin
showed at least an equal efficacy. Summary: The use of vasopressin and its synthetic
analogues has shown beneficial effects in the management of patients with cirrhosis,
especially in the context of variceal bleeding, the hepatorenal syndrome or both. In
both cases, the use of terlipressin improved survival. Therefore, in these clinical
indications, terlipressin is a part of recommendations. The role of vasopressin in
patients with septic shock remains to be precisely evaluated.
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